Two UA College of Medicine Departments Team with Banner Health for Kidney Stone CME Event

Kidney, bladder and ureteral stones (Courtesy of the R.O.C.K. Society)

The Division of Nephrology in the University of Arizona Department of Medicine and Division of Urology in the Department of Surgery have teamed up to host a 2.0 CME Dinner Lecture on “A Multidisciplinary Approach to Managing Kidney Stones” on Friday, Dec. 14, 5:30-8 p.m., at the Westward Look Wyndham Grand Resort & Spa in Tucson.  

Teaser image of event flyer for this story.Giving the keynote address will be David S. Goldfarb, MD, professor of medicine and physiology at New York University/NYU Langone Health, nephrology chief at the VA New York Harbor Healthcare System and past president of the R.O.C.K. Society and New York Society of Nephrology. His topic will be “Update on Nephrolithiasis”—or the process by which kidney stones are formed.

To add this event to your personal schedule (via iCal, MSOutlook, Google or Yahoo! calendar), click here.

View, post and share the flyer for this event: PDF icon CME Kidney Stone Dinner 12 14 2018.pdf

This event takes advantage of expertise with a new Stones Clinic launched at Banner – University Medicine North, 3838 N. Campbell Ave., Building 2, by the Divisions of Nephrology and Urology in coordination with the nutritional sciences team at the UA and Banner Health in mid-September. About 100 clinicians are anticipated in attendance, including community providers, primary care physicians, nurse practitioners, nephrologists, urologists, physician assistants, nurses and dietitians.

Affecting 200,000 in U.S. a Year

According to the National Kidney Foundation, it’s estimated one in 10 people will have a kidney stone at some time in their lives, the prevalence of which increased by about 5 percent (3.8% to 8.3%) from the late 1970s to the late 2000s. Men are 10 percent more likely to suffer from kidney stones (19% versus 9% in women), with a first incident more likely to occur after age 30 and reccurring incidences frequent.

Other physicians and a registered dietitian from the UA and Banner – University Medicine in Tucson also will speak on related topics at the event. They include:

  • Drs. Sireesha Koppula, Benjamin Lee, David Tzou and dietitian Kathryn Taylor“Multidisciplinary Approach to Kidney Stones” - Sireesha Koppula, MD, physician executive, population health and clinical informatics, Beaumont Medical Group, Detroit, Mich. (recently of the UA Division of Nephrology)
  • “AUA Guidelines for Surgical Treatment of Kidney Stones” - Benjamin R. Lee, MD, professor of surgery; chief, Division of Urology; director, Genitourinary (GU) Cancer - Disease Oriented Strategic Planning Team, University of Arizona College of Medicine – Tucson
  • “Radiation Safety in Stone Patients” - David T. Tzou, MD, assistant professor of surgery, Division of Urology, UA College of Medicine – Tucson
  • “Evidence-Based Nutrition Recommendation for Prevention of Kidney Stones” - Kathryn Taylor, RD, registered dietitian and nutritionist with Banner – University Medicine in Tucson.

Drs. Sangeetha Murugapandian and Bijin ThajudeenThe lectures compliment the recent opening of a new Stone Clinic by the Divisions of Nephrology and Urology at Banner – University Medicine North, 3838 N. Campbell Ave., Clinic H, in mid-September. The clinic is led by Sangeetha Murugupandian, MBBS, and Bijin Thajudeen, MD, from Nephrology, and Drs. Lee and Tzou, from Urology. The clinic’s goal is to provide a comprehensive one-stop service for prevention and treatment of kidney stones, with special emphasis on teaching, training, clinical research and use of the latest, most effective technologies for patient care.

The clinic and the lectures are funded by Nephrology, Urology and Best Use Funds from Banner Health.

Regarding both, Drs. Lee and Murugapandian said, “We’re excited this multi-disciplinary team effort, combining Urology, Nephrology and Nutritional Services, will help improve overall awareness of complex stone disease and result in better understanding of the metabolic analyses involved and improved care delivery pathways for prevention and treatment of recurrent kidney stones.”

About the Keynote Speaker

Internationally known for his studies on kidney stones, Dr. Goldfarb received a bachelor’s degree and his medical degree from Yale University (1977 and 1981). He completed his residency training in internal medicine at NYU in 1984 and served as chief resident at the VA in 1984-85. He then completed his fellowship training in nephrology at NYU from 1985-87. Since then, he has worked full-time in the nephrology section at the New York VA and in the NYU nephrology division.

Dr. David D. GoldfarbDr. Goldfarb started the NYU Kidney Stone Prevention Program where he oversees the clinical care of kidney stone-formers and performs clinical research in kidney stone treatment and prevention. He has authored articles and book chapters on nephrolithiasis and is frequently an invited speaker on this topic nationally and internationally.

Dr. Goldfarb was among the first researchers to demonstrate genetic linkages of kidney stones in the general population. His work includes effects of intestinal bacteria on urinary oxalate excretion, the effects of foods and beverages on urine chemistry, and treatment of cystinuria—an inherited autosomal recessive disease characterized by high levels of the amino acid cysteine in the urine, leading to formation of cystine stones in the kidneys, ureter and bladder.

Dr. Goldfarb also is has collaborated with researchers in Iceland and Children’s Hospital of Pennsylvania to find other genetic causes of kidney stones. In addition to his studies on kidney stones, Dr. Goldfarb is a member of the Executive Committees of three national VA Cooperative Studies Program trials, including the recently concluded “Homocysteine Study,” a trial of high-dose folic acid for patients with kidney disease.

He has served on the medical advisory board of the National Kidney Foundation for Greater New York and the scientific advisory board of the Oxalosis and Hyperoxaluria Foundation, as well as more recently being principal investigator of clinical studies regarding cynesturia for Revive Therapeutics.

ALSO SEE:
“UA Nephrology Celebrates Busy Schedule, Multiple Successes for Third Quarter 2018” | Posted Nov. 5, 2018
“UA Nephrology, Urology, Nutritional Sciences to Launch Kidney Stone Clinic at Banner – University Medicine North in July” | Posted May 28, 2018

Release Date: 
11/20/2018 - 6:30pm